KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Gains from Investment Securities (2017 - 2025)

Cardlytics filings provide 9 years of Gains from Investment Securities readings, the most recent being -$6.1 million for Q4 2025.

  • Quarterly Gains from Investment Securities fell 56.62% to -$6.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.5 million through Mar 2026, up 15.7% year-over-year, with the annual reading at $102000.0 for FY2025, 51.43% down from the prior year.
  • Gains from Investment Securities hit -$6.1 million in Q4 2025 for Cardlytics, down from $6.1 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $59.0 million in Q2 2022 and bottomed at -$108.1 million in Q3 2022.
  • Average Gains from Investment Securities over 5 years is -$6.6 million, with a median of -$1.6 million recorded in 2021.
  • Peak annual rise in Gains from Investment Securities hit 21033.69% in 2022, while the deepest fall reached 20532.35% in 2022.
  • Cardlytics' Gains from Investment Securities stood at -$68000.0 in 2021, then plummeted by 20532.35% to -$14.0 million in 2022, then surged by 236.95% to $19.2 million in 2023, then crashed by 120.43% to -$3.9 million in 2024, then plummeted by 56.62% to -$6.1 million in 2025.
  • Per Business Quant, the three most recent readings for CDLX's Gains from Investment Securities are -$6.1 million (Q4 2025), $6.1 million (Q3 2025), and -$2.5 million (Q2 2025).